3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
85
Recurrence
14
Neoplasms, Plasma Cell
14
Lymphoma, Non-Hodgkin
9
Lymphoma
7
Leukemia, Plasma Cell
6
Immunoglobulin Light-chain Amyloidosis
5
Smoldering Multiple Myeloma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Primary Myelofibrosis
2
POEMS Syndrome
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma, B-Cell
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Fasting
2
Burkitt Lymphoma
2
Alzheimer Disease
2
Waldenstrom Macroglobulinemia
1
Vomiting
1
Vitamin D Deficiency
1
Thrombocythemia, Essential
1
Interventions
fludarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Autoimmune Diseases of the Nervous System
×
Plasma cell
×
Clear all
NCT04561557
2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1
Recruiting
36 enrolled